查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087943

血液培養檢測市場：2026-2032年全球市場預測（依產品類型、技術、檢測類型、檢體類型、實施方法、最終用戶和應用分類）

Blood Culture Test Market by Product, Technology, Test Type, Sample Type, Mode, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血液培養檢測市場將成長至 92.3 億美元，複合年成長率為 7.19%。

主要市場統計數據
基準年 2025 56.7億美元
預計年份：2026年 60.3億美元
預測年份 2032 92.3億美元
複合年成長率 (%) 7.19%

血液培養檢測仍是臨床上檢測血流感染疾病和鑑定引起敗血症的細菌和真菌的標準方法。對於醫院、臨床檢查室、診斷設備製造商和抗生素使用團隊而言，血液培養檢測在早期病原體鑑定、標靶抗生素治療、感染控制和患者風險分層方面發揮著至關重要的作用。

全球膿毒症負擔沉重，世界衛生組織 (WHO) 估計每年約有 4900 萬例膿毒症病例和 1100 萬例死亡，而抗生素抗藥性的日益普遍也加劇了對及時、病原體特異性診斷的需求，從而影響著這一市場。在醫療機構中，隨著人們越來越需要縮短檢測結果時間、避免不必要的頻譜檢體使用以及改善急診醫學、重症監護、腫瘤科、新生兒科和移植科的治療效果，自動化血液培養系統、最佳化的樣本採集、快速病原體鑑定和藥敏試驗流程變得日益重要。

血液培養檢測領域的變革性變化

血液培養檢測領域正從傳統的單純培養工作流程轉向整合式診斷路徑，該路徑結合了自動化培養、連續監測、分子鑑定、抗菌藥物敏感性試驗以及與實驗室資訊系統的整合。推動這一轉變的動力源於縮短有效治療時間的壓力，同時也要保持基於培養的診斷所具有的特異性和臨床可靠性。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過改善預測、優先排序和結果解讀，對整個血液培養工作流程產生了累積的影響。 AI 驅動的臨床決策支持有助於識別膿毒症高風險患者，促進在應用抗生素前進行適當的血液培養檢體採集，並減少急診和住院治療過程中的延誤。在檢查室中，機器學習可以輔助解讀檢測結果、預測工作量、分析陽性檢體、監測污染和品管。

關鍵區域洞察

亞太地區是血液培養檢測應用最活躍的地區之一。這主要得益於中國、印度、日本、韓國和澳洲等國醫院基礎建設的持續改善、感染疾病負擔沉重，以及對自動化微生物檢測投入的增加。此外，對抗生素抗藥性監測的需求、都市區私人實驗室網路的擴張，以及三級醫療機構對敗血症治療日益重視，都進一步推動了血液培養檢測的需求。

關鍵群體特定見解

在東南亞國協，隨著各國政府加強醫院網路、感染疾病監測和檢查室認證，以及都市區三級醫療機構的發展和人們對抗生素抗藥性認知的提高，血液培養檢測能力正在不斷提升。在海灣合作理事會國家，作為更廣泛的醫療現代化計劃、醫療城建設和三級醫療機構擴張的一部分，對高通量自動化微生物檢測系統的投資正在穩步推進。歐盟則透過體外診斷醫療設備法規、抗菌藥物抗藥性計畫和協調的公共衛生監測，持續影響全球標準。

主要國家的概況

美國憑藉先進的膿毒症診療方案、大規模的醫院網路以及美國疾病控制與預防中心（CDC）主導的抗生素抗藥性和醫療相關感染疾病防治工作，在行業中處於領先地位。加拿大強調標準化的檢查室品管和合理使用抗生素，而墨西哥和巴西則透過公私混合醫療系統擴大診斷服務的覆蓋範圍。英國、德國、法國、義大利和西班牙擁有強大的臨床微生物學能力，其中德國和法國尤其在檢查室自動化、合理使用抗生素和醫院感染疾病控制方面展現出顯著優勢。

為行業領導者提供的實用建議

產業領導者應優先考慮工作流程整合型創新，以在不影響培養可靠性的前提下縮短病原體鑑定所需時間。這包括提高採集前檢體品質、最佳化血量標準執行、整合陽性檢體快速鑑定、改進抗菌藥物敏感性測試工作流程，以及實現與實驗室資訊系統和抗菌藥物合理使用平台的無縫整合。

調查方法

本執行摘要基於醫療保健、公共衛生、監管和臨床微生物學領域的權威二手研究，包括世界衛生組織 (WHO)、各國公共衛生機構提供的關於膿毒症和抗生素抗藥性的全球證據、同行評審的臨床指南以及經認證的檢查室操作規範。本分析重點在於已證實的採納促進因素、工作流程趨勢、區域醫療保健背景以及與血液培養檢測相關的技術發展。

結論

血液培養檢測在血流感染疾病的診斷和治療中仍然至關重要。由於敗血症死亡率上升、抗生素抗藥性蔓延以及醫院品質要求日益嚴格，對可靠微生物檢測的需求日益成長。目前的趨勢是朝著更快、更互聯、更自動化的工作流程發展，既能維持血液培養檢測的診斷權威性，又能加快臨床反應速度。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 血液培養檢測市場：依產品分類

  • 消耗品
    • 瓶子
    • 培養基
    • 試劑組
  • 裝置
    • 分析器
    • 自動化系統

第8章 血液培養檢測市場：依技術分類

  • 傳統的
  • 分子
    • 次世代定序
    • 聚合酵素鏈鎖反應

第9章 血液培養檢測市場：依檢測類型分類

  • 自動化
  • 手動的

第10章 血液培養檢測市場：依樣本類型分類

  • 電漿
  • 全血

第11章 血液培養檢測市場：依模式分類

  • 中心檢查室
  • 照護現場
    • 床頭
    • 可攜式的

第12章 血液培養檢測市場：依最終用戶分類

  • 門診部
    • 獨立診所
    • 診所
  • 血庫
  • 診斷檢查室
    • 醫院檢查室
    • 獨立檢測實驗室
  • 醫院和診所
    • 二級醫療機構
    • 三好醫院

第13章 血液培養檢測市場：依應用領域分類

  • 細菌
    • 革蘭氏陰性菌
    • 革蘭氏陽性菌
  • 真菌
    • 絲狀真菌
    • 東方
  • 分枝桿菌

第14章 血液培養檢測市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章 血液培養檢測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 血液培養檢測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Abbott Laboratories
  • Anaerobe Systems, Inc.
  • Autobio Diagnostics Co., Ltd.
  • Becton, Dickinson and Company
  • BINDER GmbH
  • Biobase Biodusty（Shandong）, Co., Ltd.
  • Biomerieux SA
  • Bruker Corporation
  • Danaher Corporation
  • Devyser AB
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • HiMedia Laboratories Pvt. Ltd.
  • Juno Diagnostics, Inc.
  • Neogen Corporation
  • Novartis AG
  • OpGen, Inc.
  • Scenker Biological Technology Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • T2 Biosystems, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • ZeptoMetrix Corporation
Product Code: MRR-035DA3C63737

The Blood Culture Test Market is projected to grow by USD 9.23 billion at a CAGR of 7.19% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.67 billion
Estimated Year [2026] USD 6.03 billion
Forecast Year [2032] USD 9.23 billion
CAGR (%) 7.19%

Blood culture testing remains the clinical reference standard for detecting bloodstream infection and confirming sepsis-causing bacteria and fungi. For hospitals, clinical laboratories, diagnostic manufacturers, and antimicrobial stewardship teams, the blood culture test is central to early pathogen identification, targeted antimicrobial therapy, infection control, and patient risk stratification.

The market is being shaped by the global burden of sepsis, which the World Health Organization links to approximately 49 million cases and 11 million deaths annually, and by rising antimicrobial resistance that increases the need for timely, organism-specific diagnosis. Automated blood culture systems, optimized sample collection, rapid organism identification, and susceptibility workflows are increasingly important as health systems seek to reduce time-to-result, avoid unnecessary broad-spectrum antibiotic exposure, and improve outcomes in emergency, intensive care, oncology, neonatal, and transplant settings.

Transformative Shifts in the Blood Culture Testing Landscape

The blood culture test landscape is shifting from conventional culture-only workflows toward integrated diagnostic pathways that combine automated incubation, continuous monitoring, molecular identification, antimicrobial susceptibility testing, and laboratory information system connectivity. This transformation is driven by pressure to shorten time to effective therapy while maintaining the specificity and clinical confidence associated with culture-based diagnosis.

Operationally, laboratories are prioritizing contamination reduction, standardized collection volumes, instrument uptime, and faster downstream identification once a bottle flags positive. Health systems are also aligning blood culture testing with sepsis bundles, antimicrobial stewardship programs, and infection prevention metrics, making diagnostic performance a strategic quality indicator rather than a standalone laboratory function.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating a cumulative impact across the blood culture workflow by improving prediction, prioritization, and interpretation. AI-enabled clinical decision support can help identify patients at elevated sepsis risk, prompt appropriate blood culture collection before antibiotics, and reduce delays in emergency and inpatient care pathways. In the laboratory, machine learning can support signal interpretation, workload forecasting, bottle positivity analytics, contamination monitoring, and quality management.

The greatest near-term value is expected from AI that is embedded into validated clinical workflows rather than used as a replacement for microbiology expertise. When paired with electronic health records, antimicrobial stewardship data, and instrument outputs, AI can help reduce avoidable repeat testing, flag possible contaminants, accelerate escalation for critical results, and support more consistent reporting across high-volume hospital networks.

Key Regional Insights

Asia-Pacific is one of the most dynamic regions for blood culture test adoption, supported by expanding hospital infrastructure, high infectious disease burden, and rising investment in automated microbiology in China, India, Japan, South Korea, and Australia. Demand is reinforced by antimicrobial resistance surveillance needs, the expansion of private laboratory networks in urban centers, and increased focus on sepsis care in tertiary hospitals.

North America is characterized by mature hospital diagnostics, strong sepsis quality initiatives, antimicrobial stewardship mandates, and broad use of automated blood culture platforms. Latin America is advancing through public health modernization and private hospital growth, although access, reimbursement variability, and laboratory infrastructure gaps remain important constraints. Europe benefits from established antimicrobial stewardship frameworks, regional regulatory harmonization for in vitro diagnostics, and strong clinical microbiology standards. The Middle East, particularly high-income Gulf markets, is investing in advanced hospital laboratories and infection control capacity, while Africa continues to face access gaps but represents a critical region for bloodstream infection diagnosis due to infectious disease burden, neonatal sepsis risk, and the need for scalable diagnostic capacity.

Key Group Insights

ASEAN markets are expanding blood culture testing capacity as governments strengthen hospital networks, infectious disease surveillance, and laboratory accreditation, with demand supported by urban tertiary care growth and rising antimicrobial resistance awareness. The GCC is investing in high-throughput automated microbiology systems as part of broader healthcare modernization programs, medical city development, and tertiary care expansion. The European Union continues to influence global standards through in vitro diagnostic regulation, antimicrobial resistance action plans, and coordinated public health surveillance.

BRICS economies represent a major growth base because of large patient populations, rising healthcare expenditure, and urgent antimicrobial resistance priorities across Brazil, Russia, India, China, and South Africa. G7 countries lead in installed diagnostic infrastructure, stewardship integration, laboratory quality systems, and adoption of rapid adjunct technologies. NATO countries show strong demand resilience due to healthcare security priorities, military medicine requirements, and the need for dependable diagnostics during outbreaks, conflict-related care, and cross-border health emergencies.

Key Country Insights

The United States leads through advanced sepsis protocols, large hospital networks, and CDC-driven attention to antimicrobial resistance and healthcare-associated infections. Canada emphasizes standardized laboratory quality and stewardship, while Mexico and Brazil are expanding diagnostic access through mixed public-private healthcare systems. The United Kingdom, Germany, France, Italy, and Spain maintain strong clinical microbiology capabilities, with Germany and France showing notable strength in laboratory automation, antimicrobial stewardship, and hospital-based infectious disease management.

Russia continues to require robust bloodstream infection testing across large regional healthcare systems. China is scaling automated diagnostics rapidly as hospital volumes increase and antimicrobial resistance surveillance becomes more important. India has strong long-term demand driven by sepsis burden, private hospital investment, neonatal and intensive care needs, and the requirement for broader diagnostic access. Japan, Australia, and South Korea are advanced markets with high expectations for quality, automation, and rapid results, supported by mature hospital systems, infection control programs, and strong laboratory governance.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize workflow-integrated innovation that reduces time to organism identification without compromising culture reliability. This includes improving pre-analytical collection quality, optimizing blood volume compliance, integrating rapid identification from positive bottles, strengthening antimicrobial susceptibility workflows, and enabling seamless connectivity with laboratory information systems and antimicrobial stewardship platforms.

Commercial strategy should align with regional readiness. Mature markets need automation, analytics, interoperability, and evidence of clinical utility, while emerging markets need scalable instruments, training, service reliability, and cost-efficient consumables. Vendors and laboratories should also invest in contamination prevention, local validation studies, regulatory readiness, resilient supply chains, and partnerships with hospitals, public health agencies, and stewardship teams.

Research Methodology

This executive summary is based on secondary research from authoritative healthcare, public health, regulatory, and clinical microbiology sources, including global sepsis and antimicrobial resistance evidence from the World Health Organization, national public health agencies, peer-reviewed clinical guidance, and recognized laboratory practice standards. The analysis focuses on verified adoption drivers, workflow trends, regional healthcare dynamics, and technology developments relevant to blood culture testing.

Insights were synthesized through a structured review of disease burden, hospital laboratory modernization, antimicrobial stewardship priorities, diagnostic workflow evolution, regulatory direction, and regional health system capacity. The methodology avoids unverified market sizing claims and emphasizes data-backed directional intelligence suitable for decision-making, and strategic planning.

Conclusion

Blood culture testing remains indispensable in the diagnosis and management of bloodstream infections, particularly as sepsis mortality, antimicrobial resistance, and hospital quality requirements intensify the need for reliable microbiology. The landscape is moving toward faster, more connected, and more automated workflows that preserve the diagnostic authority of culture while accelerating clinical action.

Organizations that combine validated technology, strong laboratory practices, antimicrobial stewardship integration, and regionally tailored execution will be best positioned to support clinical value. The next phase of the blood culture test landscape will be defined by speed, accuracy, workflow intelligence, and equitable access to high-quality bloodstream infection diagnostics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Blood Culture Test Market, by Product

  • 7.1. Consumables
    • 7.1.1. Bottles
    • 7.1.2. Culture Media
    • 7.1.3. Reagent Kits
  • 7.2. Instruments
    • 7.2.1. Analyzers
    • 7.2.2. Automation Systems

8. Blood Culture Test Market, by Technology

  • 8.1. Conventional
  • 8.2. Molecular
    • 8.2.1. Next Generation Sequencing
    • 8.2.2. Polymerase Chain Reaction

9. Blood Culture Test Market, by Test Type

  • 9.1. Automated
  • 9.2. Manual

10. Blood Culture Test Market, by Sample Type

  • 10.1. Plasma
  • 10.2. Whole Blood

11. Blood Culture Test Market, by Mode

  • 11.1. Central Lab
  • 11.2. Point Of Care
    • 11.2.1. Bedside
    • 11.2.2. Portable

12. Blood Culture Test Market, by End User

  • 12.1. Ambulatory Care Centers
    • 12.1.1. Independent Clinics
    • 12.1.2. Physician Offices
  • 12.2. Blood Banks
  • 12.3. Diagnostic Laboratories
    • 12.3.1. Hospital Based Labs
    • 12.3.2. Independent Labs
  • 12.4. Hospitals & Clinics
    • 12.4.1. Secondary Hospitals
    • 12.4.2. Tertiary Hospitals

13. Blood Culture Test Market, by Application

  • 13.1. Bacterial
    • 13.1.1. Gram Negative
    • 13.1.2. Gram Positive
  • 13.2. Fungal
    • 13.2.1. Filamentous Fungi
    • 13.2.2. Yeast
  • 13.3. Mycobacterial

14. Blood Culture Test Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Blood Culture Test Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Blood Culture Test Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Abbott Laboratories
  • 18.2. Anaerobe Systems, Inc.
  • 18.3. Autobio Diagnostics Co., Ltd.
  • 18.4. Becton, Dickinson and Company
  • 18.5. BINDER GmbH
  • 18.6. Biobase Biodusty(Shandong), Co., Ltd.
  • 18.7. Biomerieux SA
  • 18.8. Bruker Corporation
  • 18.9. Danaher Corporation
  • 18.10. Devyser AB
  • 18.11. Eli Lilly and Company
  • 18.12. F. Hoffmann-La Roche Ltd.
  • 18.13. HiMedia Laboratories Pvt. Ltd.
  • 18.14. Juno Diagnostics, Inc.
  • 18.15. Neogen Corporation
  • 18.16. Novartis AG
  • 18.17. OpGen, Inc.
  • 18.18. Scenker Biological Technology Co., Ltd.
  • 18.19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 18.20. Siemens Healthineers AG
  • 18.21. T2 Biosystems, Inc.
  • 18.22. Terumo Corporation
  • 18.23. Thermo Fisher Scientific, Inc.
  • 18.24. ZeptoMetrix Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD CULTURE TEST MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BLOOD CULTURE TEST MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BLOOD CULTURE TEST MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BLOOD CULTURE TEST MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BOTTLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BOTTLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BOTTLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CULTURE MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CULTURE MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL REAGENT KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL REAGENT KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL REAGENT KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AUTOMATION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AUTOMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONVENTIONAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONVENTIONAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONVENTIONAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MOLECULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MOLECULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MOLECULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AUTOMATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AUTOMATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AUTOMATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MANUAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MANUAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MANUAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PLASMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PLASMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PLASMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL WHOLE BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL WHOLE BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL WHOLE BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CENTRAL LAB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL POINT OF CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL POINT OF CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL POINT OF CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BEDSIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BEDSIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BEDSIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INDEPENDENT CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INDEPENDENT CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INDEPENDENT CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHYSICIAN OFFICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHYSICIAN OFFICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHYSICIAN OFFICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD BANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD BANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOSPITAL BASED LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOSPITAL BASED LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOSPITAL BASED LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INDEPENDENT LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INDEPENDENT LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INDEPENDENT LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SECONDARY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SECONDARY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SECONDARY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TERTIARY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL TERTIARY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL TERTIARY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BACTERIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BACTERIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BACTERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GRAM NEGATIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GRAM NEGATIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GRAM NEGATIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GRAM POSITIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GRAM POSITIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GRAM POSITIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FUNGAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL FUNGAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL FUNGAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL FILAMENTOUS FUNGI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL FILAMENTOUS FUNGI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL FILAMENTOUS FUNGI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL YEAST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL YEAST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL YEAST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MYCOBACTERIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MYCOBACTERIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MYCOBACTERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 238. GCC BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. GCC BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 240. GCC BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 241. GCC BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 242. GCC BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. GCC BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 244. GCC BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. GCC BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. GCC BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 248. GCC BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. GCC BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 250. GCC BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 251. GCC BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. GCC BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 254. GCC BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 289. G7 BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. G7 BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 291. G7 BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 292. G7 BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 293. G7 BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. G7 BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 295. G7 BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. G7 BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. G7 BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 298. G7 BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 299. G7 BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. G7 BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 301. G7 BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 302. G7 BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 303. G7 BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 304. G7 BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 305. G7 BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 306. NATO BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. NATO BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 308. NATO BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 309. NATO BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 310. NATO BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 311. NATO BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 312. NATO BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. NATO BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. NATO BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 315. NATO BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 316. NATO BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. NATO BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 318. NATO BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 319. NATO BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 320. NATO BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. NATO BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 322. NATO BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 323. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 341. CANADA BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 342. CANADA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 343. CANADA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 344. CANADA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 345. CANADA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 346. CANADA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 347. CANADA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 348. CANADA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 349. CANADA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 350. CANADA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 351. CANADA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 352. CANADA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 353. CANADA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 354. CANADA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 355. CANADA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 356. CANADA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)
  • TABLE 357. CANADA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2018-2032 (USD MILLION)
  • TABLE 358. MEXICO BLOOD CULTURE TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 359. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 360. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 361. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 362. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 363. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
  • TABLE 364. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 365. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 366. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 367. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2018-2032 (USD MILLION)
  • TABLE 368. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 369. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 370. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 371. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 372. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 373. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2018-2032 (USD MILLION)

TABLE